Irvine Scientific Introduces New Cell Therapy Products For Cell Expansion And Differentiation

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a strategic manufacturer of cell culture media, announced today the expansion of their cell therapy product portfolio with the launch of new media and recombinant growth factors. The product line is designed to provide an integrated workflow solution for the culture of human stem cells and primary cells. In addition to the existing PRIME-XVTM MSC Expansion SFM medium, intended for the expansion of human mesenchymal stem cells, Irvine Scientific is introducing three new media. These new formulations are used for neural progenitor cell (NPC) expansion, amniotic fluid stem cell (AFSC) expansion and tumorsphere formation. To facilitate clinical applications, these media are manufactured in an ISO13485 certified facility and have pending Drug Master Files.

Help employers find you! Check out all the jobs and post your resume.